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Background: Nested within a large, multicenter randomized controlled trial (RCT) for people with dissociative
seizures (DS), the study used purposive sampling to explore participants' experience of participating in an
RCT, their experience of DS-specific cognitive behavioral therapy (CBT) and another component of the RCT, Stan-
dardized Medical Care (SMC) and their perceptions of and reflections on seizure management and change.
Methods: A qualitative study using semistructured interviews was conducted with 30 participants in an RCT (the
COgnitive behavioral therapy vs standardized medical care for adults with Dissociative non-Epileptic Seizures
(CODES) Trial) investigating the effectiveness of two treatments for DS. Key themes and subthemes were iden-
tified using thematic framework analysis (TFA).
Results: Analysis yielded three overarching themes: taking part in a treatment trial — “the only thing out there”,
the experience of treatment techniques thatwere perceived to helpwith seizuremanagement, and reflections on
an “unpredictable recovery”.
Conclusions: People with DS are amenable to participating in a psychotherapy RCT and described a largely positive
experience. They also described the applicability of aspects of DS-specific CBT and SMC in the management of their
DS, receivedwithin the confines of the CODES trial. Factors that appeared to account for the variability in response to
treatment delivery included individual preferences for the nature of sessions, the nature of therapeutic relationships,
readiness to discuss trauma, other aspects of emotional avoidance, and whether therapy provided something new.
© 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
Keywords:
Dissociative seizures
Cognitive behavior therapy
Seizure control
Change
Qualitative
1. Introduction
Dissociative seizures (DS) are paroxysmal events that resemble epi-
leptic seizures or syncope but are not associated with abnormal brain
electrical activity that would indicate epilepsy and are not explained
by other medical conditions. They are understood as a dissociative re-
sponse to potentially provoking internal or external stimuli [1]. Disso-
ciative seizures are more common in women and are often initially
misdiagnosed as epilepsy or syncopewhile the correct diagnosis is com-
monly delayed by several years [2]. DS are associated with high rates of
comorbid psychopathology [3,4] aswell as other functional neurological
or somatic symptoms [5]. Dissociative seizures and epilepsy can also co-
occur [6]. Importantly, it has been noted that previous psychological
trauma, while common, is not essential for the diagnosis [4].
Recent research into the phenomenology and semiology of DS has led
to the development of biopsychosocial models of the condition. While a
variety of factors lead to the maintenance of DS [7], fear and avoidance
may be conceived as particularly important targets for therapy since
they may lead to a wide range of everyday activities being altered or
avoided [8], consistent with the fear-escape avoidancemodel [9]. One ap-
proach using cognitive behavioral therapy (CBT) has indeed built upon
the fear-avoidance model leading to a series of treatment studies
[8,10,11] and culminating in the first sufficiently powered randomized
controlled trial (RCT) to compare treatments for patients with DS, i.e.,
the COgnitive behavioral therapy vs standardized medical care for adults
with Dissociative non-Epileptic Seizures (CODES) trial [12].
Previous qualitative research with patients with DS is summarized
well in Rawlings and Reuber's [13] systematic synthesis that included
21 studies from the previous 20 years. Characteristic of these studies
was a small sample size of 5–15 participants. Many of these studies
noted the crippling isolation and debilitating effects of long-term DS.
One study examining participants' perceptions of DS after a
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psychoeducational program, reported mixed results in terms of percep-
tions of improvement [14]. Fairclough et al. [15] explored patients' con-
cerns and understanding prior to psychological treatment and found
apprehension about whether psychological treatment would meet
their needs. Other studies focused on describing the heterogeneous na-
ture of DS disorders, problems surrounding the differential diagnosis,
the burden of DS, and difficulties surrounding emotional processing
and treatments [13,16].
There is a paucity of research on patientswith Functional Neurological
Disorder (FND),much lessDS, participating in anRCT involving a complex
intervention. This paper seeks to address the knowledge gap about the
experience of people with DS taking part in an RCT more generally and
their experience of the specific interventions within the CODES RCT. We
wanted to know more about the techniques or treatment in both arms,
whichwere perceived by participants to bring about change. Undertaking
qualitative work of this nature can help shed light on why treatment
might be successful but also what might explain treatment failure.
2. Materials and methods
2.1. Interventions and outcomes in the CODES study
In the CODES RCT, 368 individuals with DS were randomized to re-
ceive Standardized Medical Care (SMC) alone or DS-specific CBT in ad-
dition to SMC (CBT + SMC) [12].
Standardized Medical Care involved a formalized approach to the
delivery of the diagnosis at the neurology/specialist epilepsy clinic and
twodifferent information factsheets— oneprovided by neurologists fol-
lowing initial diagnosis and one by psychiatrists at the subsequent neu-
ropsychiatric assessment (see http://www.codestrial.org/information-
booklets/4579871164). Following the diagnosis by a neurologist,
where the diagnosis and rationale for referring the patient to a psychia-
trist were explained [12], around three months later liaison or neuro-
psychiatrists carried out further assessments of etiological and
maintaining factors, treated complex comorbidity, offered psychophar-
macological interventions (as appropriate), and gave advice on seizure
management but were instructed to avoid using CBT techniques. Stan-
dardized Medical Care follow-up appointments were primarily offered
by the CODES psychiatrist but also, to a lesser extent, by the CODES di-
agnosing neurologist. We suggested that neurology SMC follow-up ses-
sionsmight review progress and the patient's ongoing understanding of
their diagnosis, overseewithdrawal of antiepileptic drugs if appropriate,
provide management for comorbid physical conditions, and reassess
where appropriate major psychiatric risk; neurologists could also insti-
tute psychopharmacological treatments for anxiety or depression prior
to the psychiatric assessment in cases of clinical need and could help
with the completion of any government department forms e.g.,
concerning driving. As part of the psychiatrists' input [12], there was
the opportunity for them to provide general information about any
warning symptoms concerning DS and distraction, but the intention
was that particular techniques would not be covered so that this did
not become therapy as such. Psychiatrists were also able to liaise with
other mental health professionals involved in the person's care and
refer to crisis teams if necessary, but referrals for other psychotherapy,
specifically for DS, was not to be made; it was intended that psychia-
trists would manage patients' symptoms in the usual way. While we
did not prescribe the number of SMC sessions to be offered, since
these may have been influenced both by local service availability and
also patients' clinical need, we anticipated that there might be up to
two SMC sessions offered by neurologists following diagnosis delivery
and three to four SMC sessions offered by psychiatrists [12].
Those randomized to CBT in addition to SMC (CBT + SMC) were of-
fered a DS-specific CBT intervention comprising of 12 one-hour-long
sessions intended to occur over four to fivemonths delivered by qualified
CBT therapists, with a further booster session ninemonths after random-
ization. Therapy was manualized with guidance for each session but was
individualized and formulation-driven and allowed flexibility in treat-
ment delivery. In addition to engaging participants and providing
psychoeducation — in particular teaching techniques to assist with sei-
zure control— the intervention addressed avoidancebehavior, identifying
and challenging seizure-related cognitions, addressing traumawhere rel-
evant, and devising a plan for relapse prevention [17]. Therapists received
training in delivering the DS-specific CBT by the CODES team and were
supervised during the trial. Patients were provided with their own hand-
book containing supportingmaterial for the intervention. Because of ran-
dom allocation to treatment arms within an RCT, all patients randomized
after receiving the diagnosis from a neurologist and undergoing
prerandomization assessment by a psychiatrist were considered eligible
for CBT in the study, unlike in routine clinical practice where patients
might undergo further screeningof their suitability for treatment andmo-
tivation to change by a therapist prior to commencement of CBT.
The primary outcome of the RCT was monthly DS frequency evalu-
ated at 12 months postrandomization. Secondary outcomes included
other measures related to DS occurrence including participants' ratings
of how severe and bothersome they found their DS, the longest number
of consecutive dayswithoutDS in the last sixmonths of their time in the
study, whether or not they were completely seizure-free in the final
three months of the study, and whether or not their DS frequency re-
duced by more than 50%. Other secondary outcomes evaluated at 12
months covered a range of measures of psychological and psychosocial
status including self-rated quality of life, depression, anxiety, distress,
numbers of somatic symptoms, psychosocial functioning, and clinician
and self-rated improvement as well as satisfaction with treatment.
More details are provided elsewhere [12].
2.2. Participants
Purposive sampling was carried out with consideration of matching
age, gender, ethnicity, and geographic characteristics of the sample in
the broader RCT and was used to select 30 participants who had re-
cently completed the CODES trial. They had previously consented to
being contacted for an interview once they had finished the final fol-
low-up assessment, a year following randomization. There was a delib-
erate weighting towards participants who had received the DS-specific
CBT given the need to understand more about participants' experience
of this intervention. We also selected some participants who were am-
bivalent about their treatment or who did not engage with the full
course of treatment, to enable us to capture a range of views. Eligibility
criteria for the CODES Trial are described elsewhere [12] but included
patients with a previous diagnosis of epilepsy but who had not experi-
enced an epileptic seizure in the previous year at the time of consent
to the RCT. Twenty-one women and nine men were interviewed by re-
searchers from the CODES team. A further two people were approached
but declined to take part. All those participating gave written informed
consent; consent was reconfirmed at the time of the interview. The
CODES study received ethical approval from the London - Camberwell
St Giles Research Ethics Committee (reference 13/LO/1595).
2.3. Interview schedule
The interview schedule (see Supplementary Material 1) was devel-
oped by several researchers in the CODES team to ensure clinical rele-
vance and methodological rigor. The schedule was also discussed with
a Service User (i.e., a patient representative) involved in the wider
CODES project. The topics of relevance to the current paper were a)
the experience of taking part in the CODES trial, b) their views on the
treatment towhich theywere assigned, and c) their perception of treat-
ment outcome. The remaining topics that were explored (participants'
experience of receiving the diagnosis and the impact of DS on their
life) will be reported elsewhere. A mid-way review of the interview
schedule resulted in the addition of a further question that asked
whether any reduction in DS had been accompanied by increased
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anxiety or depression. This addition arose because two participants
interviewed by that point had said that this had been their experience.
Positive as well as negative reflections were encouraged.
2.4. Data collection
Between February 2016 andMay 2018, three researchers conducted
the semistructured interviews in England and Scotland; one researcher
(JR) conducted and transcribedmost of the interviews. Twenty-five par-
ticipants were interviewed at home, four participants from one NHS
Trust were interviewed in a local hospital, and one participant re-
quested the interview be at the CODES research worker's university of-
fices. Interviews lasted between45 and 90min andwere recorded on an
encrypteddigital voice recorder. Three of the interviewees had one fam-
ily member or partner present.
2.5. Data analysis
Four members of the research team contributed to the verbatim
transcription of the interviews. Participants' nonverbal cues were not
included. Participant pseudoanonymitywas ensured both in the record-
ing and in the transcripts by using ID numbers. Healthcare professionals
named in the recordings were anonymized in the transcriptions.
We adopted thematic framework analysis (TFA) [18], which is
viewed as a useful approach to the analysis of qualitative data when a
multidisciplinary team of researchers is involved in conducting qualita-
tive research, and while initially devised for large-scale policy research,
it is also used for health research [19] especially where research sets out
to obtain answers to specific problems. Thus, the study's objectives
must clearly relate to what is being asked about [18]. The approach is
appropriate for use in mixed-methods research projects with multiple
researchers [19,20]. UnlikeGrounded Theory, TFA is not used to develop
theory and is not linked to a particular theoretical, philosophical, or
epistemological approach [19].
The qualitative analysis employed here comprised five stages.
1) The lead researcher (JR) initially read and re-read the transcripts
in a process of familiarization with the data. Using NVivo v12 software
(QSR International), each line of the transcripts was read and coded
by the lead researcher (JR) in both a deductive way (in line with the a
priori aims of the study) and then in an inductive way with multiple
open codes. A second researcher (HJ) followed the same procedure
and coded a total of eight randomly chosen transcripts relating to inter-
views from both trial arms. Coding meetings between the two re-
searchers and the other members of the research team showed
considerable agreement in coding and in the definition of themes aris-
ing from the grouping of codes into categories. 2) A working theoretical
framework was developed from these categories. 3) This framework
was then applied back to all subsequent transcripts for indexing to see
how the raw data fitted this framework. 4) Adjustments to the frame-
work were made as necessary. A matrix was developed on NVivo, and
excerpts of raw data were presented in a chart to illustrate a given cat-
egory [18]. 5) In a final stage – ‘mapping and interpretation’ [21] – the
lead researcher considered the connections and patterns between the
charted categories and any explanations that might account for these
connections.
3. Results
3.1. Participants
Twenty-two patients allocated to CBT + SMC and eight patients al-
located to SMC were interviewed. See Table 1 for participant
characteristics.
One participant had concurrent controlled epilepsy, eight had a con-
firmed previous misdiagnosis of epilepsy, and one still felt that his sei-
zures could be a mixture of the two, despite clinical opinion that his
diagnosis was only DS. More women than men were interviewed to re-
flect thehigher prevalence of DS amongwomen in the CODES study [22]
and the population with DS more widely. The majority (20/22) of par-
ticipants randomized to receive CBT who were interviewed here
attended at least nine CBT sessions and were therefore classified as
compliant with the DS-specific CBT in the study [23]. Those inter-
viewees allocated to CBT+ SMC attended amedian of 3.5 SMC sessions
(range: 0–10 sessions), while those patients allocated to SMC-alone
attended a median of 4 SMC sessions (range: 2–6 sessions). At the
time of their diagnosis by a CODES neurologist, none of the participants
reported any previous knowledge of DS.
3.2. Themes
Three superordinate themes relating to participating in the trial and
treatment emerged from the TFA and are discussed in this paper. The
three themes were the following: a) the experience of taking part in a
treatment trial — “the only thing out there”, b) treatment techniques
that were perceived to help with seizure management, and c) and re-
flections on an “unpredictable recovery”. The three themes and their
subthemes are listed in Table 2.
3.2.1. Participating in a treatment trial — “the only thing out there”
3.2.1.1. “The chance of something changing”. Eighty percent of all the in-
terviewees said they consented to take part in the trial because it offered
them hope in relation to treatment. Sixty percent recalled how before
the trial, they had felt low, desperate, and lost. Common responses in
their accounts of why they took part were expressions such as “there's
Table 1
Demographics of participants.
Demographic characteristic N %
Age at interview (years)
18–30 10 33.3
31–40 6 20
41–50 7 23.3
51–60 2 6.6
61–80 5 16.6
Gender
Female 21 70
Male 9 30
Ethnicity
White British 28 93.3
Other 2 6.7
Treatment received
CBT + SMC 22 73
SMC alone 8 27
Number of CBT sessions attended
12 sessions + booster session 14 63.6
12 sessions 1 4.5
11 sessions 3 13.6
10 sessions 1 4.5
9 sessions 1 4.5
5 sessions 1 4.5
1 session 1 4.5
Duration of DS
b1 year 5 16.7
1–4 years 11 36.7
5–9 years 4 13.3
10–14 years 4 13.3
15–19 years 2 6.7
20–24 years 2 6.7
25–29 years 0 0
30–34 years 1 3.3
35–39 years 0 0
40–44 years 1 3.3
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nothing else out there” or “the chance of something changing”, espe-
cially for those for whom there had been a query as to whether the sei-
zures were epileptic. Seven participants said that they had also taken
part as maybe it would help further research and treatment for others.
3.2.1.2. CODES health professionals — “people who understand”. While
many did not comment on this, just over half of all participants from
the total of 30 interviewed expressly indicated that they had felt under-
stood by the CODES health professionals (including the research
workers who enrolled them into the trial), which in turn, stopped
them feeling so alone and isolated:
“It sort of gets you talking to people and gets you out the house, because
you're going to appointments … You know it's not just – you've
invented it, that's why you're staying in the house all on your own
and it kind of makes you think – right okay it's an actual problem and
people are actually dealing with it and other people have it as well”.
(Female, SMC, interview 29)
Five participants recalled feeling apprehensive about having to see
the CODES neuropsychiatrist as they were concerned about the stigma
of having amental illness, attending hospital appointments, and the im-
plications of others finding out:
“It's just so annoying that the world is so taboo about mental health full
stop. So, when you hear about the Psychiatry side…it's like oh God”.
(Female, CBT + SMC, interview 28)
One participant in the SMC arm recalled liking the psychiatrist but
feeling frustrated that he asked too many times about suicide risk and
how he felt before a seizure (something he could never remember).
“That can be a minor frustration for me as well, when people in medical
profession say ‘what happens when you have one’ and I say to them ‘I
don't know’, you know, I black out I go down next thing I know is I'm
coming round couple of minutes later”.
(Male, SMC, interview 4)
3.2.1.3. The process of randomization and treatment expectation. Almost
all participants expressly said that they had understood the rationale
of being randomized and that it had been explained to them fully by
the CODES team as they moved into the trial; no one specifically indi-
cated that they had not understood the rationale for randomization.
There was a range of responses to how participants had felt about
being randomized to one of the two treatment arms. In relation to
what treatment arm theywere randomized to, half of those interviewed
said they remembered wanting as much treatment as the trial could
offer (i.e., CBT in addition to SMC). However, a further nine recalled feel-
ing hesitant about the possibility of receiving the (additional) psycho-
therapy and cited a range of obstacles such as how therapy would be
painful in terms of “dragging up the past”, that it would be too big a
commitment in terms of travel or, incorrectly, that it would mean
being in group therapy that they did not want.
Nearly two-thirds of the CBT + SMC participants and just over a
third of the SMC participants felt that the experience of the trial had
been very positive, citing outcomes such as improved quality of life, sei-
zure reduction, validation by the health professionals of their DS, or
their own acceptance of DS:
“I feel really lucky to have been part of it. I'm the kind of person who is
always trying to help other people and do this and do that. When you're
in it you're not thinking like that, you're not thinking oh they can use
me, it's more like I'm getting all this help and if I hadn't got that diagno-
sis and that study hadn't been running, don't know where I'd be now. I
could still be as bad as I was, so it was a wonderful thing.”
(Female, CBT + SMC, interview 20)
However, three males and one female participant in the SMC group
and one female and one male in the CBT + SMC group felt that while
participating in the trial had been largely positive, in terms of the treat-
ment itself, it had either not been enough or not what they wanted. Of
these, amale participant in the CBT+ SMC groupwho had previous ex-
perience of counseling refused to engage with CBT techniques or com-
plete homework. He dropped out at session 9.
“I wanted to talk about things andwhether they listenedwas entirely up
to them. Just talking about it made me feel better.”
(Male, CBT + SMC, interview 21)
One female participant, who dropped out of CBT after two sessions,
felt frustrated by aspects of the trial. She stopped attending CBT at ses-
sion 2 because she did not feel emotionally ready to discuss her trauma.
“Cos normally when I have therapy it's about the future…she (the ther-
apist) was talking about digging up pain. I didn't feel like I was clever
enough. I didn't feel like I was emotionally clever enough to be doing
that so far away from home as well.”
(Female, CBT + SMC, interview 15)
She also felt irritated that she could not then disclose to the trial re-
search worker (who phoned her fortnightly for her seizure diary) her
reasons for stopping as he would then become unblinded to her treat-
ment arm.
The female participant in the SMC group felt that while she had felt
understood initially in the trial, she had wanted more treatment than
SMC and had not experienced a positive relationship with the
psychiatrist.
“I feel like every time I see him he's got me so worked up that he wants
me to believe this thing (dissociative seizures) but he's given no help or
advice tome rather than if I say the wrongword (epilepsy) he's quick to
snap and say it's not that.”
(Female, SMC, interview 1)
3.2.2. Treatment components perceived to be helpful
3.2.2.1. The benefit of written materials — “I thought they were describing
me”. Irrespective of the arm to which patients were randomized, all
had received written booklets on DS, one at the time of diagnosis by
the neurologist and a further one at the psychiatry assessment.
Twenty-two trial participants (over two-thirds of the total sample) ex-
pressly indicated that, in addition to the explanation provided by the
neurologist, the CODES Factsheets offered them the opportunity to fur-
ther understand their condition and helped them explain the condition
Table 2
Overarching and subthemes arising from the interviews.
Overarching theme Subthemes
Participating in a treatment trial —
the “only thing out there”
a) “The chance of something changing”
b) CODES Health Professionals: “People who
understand”
c) The process of randomization and
treatment expectation
Treatment components perceived
to be helpful
a) The benefit of written materials — “I
thought they were describing me”
b) “Finding out a bit more about who I am” —
the benefits of a good therapeutic
relationship
c) “Focusing on my breathing” — techniques
that help feelings of control
d) Challenges to the implementation of CBT
Reflections on an “unpredictable
recovery”
a) Personal insights into DS and attributions
for “getting my life back”
b) Accepting partial improvement
c) Ongoing support
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to others, including other people involved in their care such as general
practitioners:
“I remember crying I think cos I was just so, finally…“this is what I've
got, this isme, thismakes sense”. I remember saying “this isme”. To have
that there was really helpful. I definitely know that there needs to be so
much more about that.”
(Female, CBT + SMC, interview 3)
Writtenmaterials supporting the CBT sessionswere also found to be
useful for participants reporting poor memory. As one participant
reported:
“So if you have something visual you can feel that you're getting anxious
or you can feel that it's a time of stress and you can go to that, pick it up
and look at it and go right okaywell this is what I did before. Did it work
last time? Yes, brilliant. And it's also a way of stepping back because you
have to stop and you have to look at it and that in itself can sometimes
just be the difference between going overwhelmed and going off the
boiling point”
(Female, CBT + SMC, interview 23)
Nonetheless, not all participants read the booklets in detail, with one
in the CBT + SMC arm indicating that they had not wanted to, and one
in the SMC alone arm indicating that she had difficulty reading anything
in a book format. A further person in the SMC arm felt that they did not
provide him with any new information.
3.2.2.2. “Finding out a bit more about who I am” — the benefits of a good
therapeutic relationship. Fifteen of the 22 participants who were ran-
domized to receive CBT + SMC described a positive relationship with
the CBT therapist and felt that this had been a key component in their
improvement. Two further participants talked about the content of the
CBT sessions rather than the actual relationship. One of the participants
(mentioned in Section 3.2.1.3) who dropped out at the second CBT ses-
sion said that she had not formed any alliance with the therapist; an-
other person (also quoted in Section 3.2.1.3) described a positive
alliance but, as indicated earlier, wanted to keep talking in sessions
rather than engage in CBT techniques. While several said they recalled
feeling an initial fear of having to talk to someone, their ability to trust
the therapist gradually built up over time and, in a few cases, prompted
them to newly disclose trauma.Many of the participants recalled feeling
that their therapists were extremely skilled at their ability to ask the
right questions.
“(The CBT Therapist) had a way with you to get you to talk about it
without even knowing you're doing it”
(Male, CBT + SMC, interview 11)
“I looked forward to every meeting, because I had something to share,
something progressive, my progress to share and they would always
be very encouraging and probably it's not the best word to use but
proud. Really happy for me and obviously…they kept saying to me it's
what you're doing but obviously it was what they were doing too.”
(Female, CBT + SMC, interview 17)
There was a range of opinions regarding the SMC sessions and not
everyone commented on their relationship with the psychiatrist.
Twelve out of the 30 participants across the two treatment arms clearly
felt that the SMC sessions with the psychiatrist had been helpful or that
they felt listened to. Of the 12, some commented on how the sessions
provided a positive and nonjudgmental space in which they could
speak at ease about whatever they wanted to discuss. Others
commented positively on the fact that the psychiatrist had offered
help should they need it in the future. They also reflected how the
CODES psychiatrist had reinforced the diagnosis in a way that they
believed was beneficial in terms of accepting and understanding it. For
the majority of the remainder, there was no specific comment.
The benefits from SMC sessions with the psychiatrist were reflected
in differentways. For two participants in the CBT+SMCgroup, the easy
relationship with the psychiatrist allowed them to compliment the ses-
sional work with the CBT therapist and deal with the consequences of
disclosing childhood trauma, suggesting some benefit from the multi-
disciplinary input in the trial. For one male SMC-alone participant, the
positive relationship with the psychiatrist, who had been instrumental
in making the DS diagnosis prior to his participation in the RCT, was
key to his progress in the trial. He felt he could talk openly without feel-
ing judged. He and one other SMC-alone participant reflected how un-
sure they were that they would have coped with CBT as they felt that
the meetings with the psychiatrist were sufficient. However, one SMC-
alone female participant said she felt unsupported by both the neurolo-
gist and the psychiatrist in her coming to termswith aDSdiagnosis after
being originally misdiagnosed with epilepsy and having taken antiepi-
lepsy medication for years.
3.2.2.3. “Focusing on my breathing” — techniques that help feelings of con-
trol. The disabling physical and psychological impairment brought
about by DS combined with the widely varying semiology, both be-
tween and within individuals, left many of the participants in this
study feeling “out of control”. This absence of control was not just in re-
lation to the seemingly random nature of DS but was exacerbated by
their other comorbid health conditions. Participants reported feeling
that they had no control not just over seizures but also over their bodies
and minds. They described how this feeling was more acute during the
often lengthy process of receiving the correct diagnosis. It follows then
that the introduction of any perception of control may be important to
individuals with DS. CBT therapists introduced participants to a range
of techniques and exercises to help in the management of seizures in-
cluding, but not exclusively, progressive muscle relaxation, breathing,
distraction and refocusing, visualization, and graded exposure. Control
was discussed in the interviews only in relation to CBT techniques.
Participants in the CBT + SMC group indicated that there were ben-
efits from being able to choose from a range of techniques the ones that
suited them best. Eighteen of the 22 CBT+ SMC participants found that
learning to control and slow down their breath by breathing from the
stomach or breathing through pain helped them relax and even divert
a seizure:
“She (CBT therapist) said you're getting the anxiety, which is building
up as muscle tension, and to release it you need to breathe through it.
Um so I breathed through that and once I had released the pain from
my stomach, I could then face the problems in front of me.”
(Female, CBT + SMC, interview 27)
Thirteen CBT+ SMC participants who found it helpful said that they
continued to use this technique for DSmanagement after treatment had
ended. One SMC-alone participant, who had researched techniques on-
line, also found controlled breathingwas helpful. Seven of the 22 CBT+
SMC participants found that distraction was particularly useful for di-
verting or preventing seizures, including two people who had found
that breathing deeply made them feel light-headed or dizzy.
In the CBT+ SMC group, the self-management or control of seizures
was often reflected in participants' ability to understand the triggers
and to then recognize the warning signs. Increased control was often
linked by participants to the start of improvement, and a gradual aware-
ness of warning signs led to some being able to postpone the seizure
until they had found a “safe place”. One female participant reflected
that she had already been practicing an element of control over the sei-
zures before the trial but talking to the CBT therapist or CODES psychi-
atrist gave her confirmation that this was the right thing to do. Some,
as they recovered, were able to divert or even completely avoid a
seizure:
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“I guess on some level I was aware that, it wasn't just going to happen
out of the blue, I knew when it was coming and yeah. I always knew, I
guess, that I could put it off. But I don't think it was until I started going
through the trial and having the CBT that I realised that I could control, I
had complete control over that and I could use that to make myself bet-
ter”
(Female, CBT + SMC, interview 24)
For six of the 22 receiving CBT+ SMC, having more control over a
seizure meant that allowing one to happen was more a “conscious
decision”. However, there were discordant views about participants'
perceived ability to control seizures. Not everyone felt that they had
warning signs. One participant who had disengaged from CBT to-
wards the end felt learning any techniques would be pointless as
he had no warning signs of a seizure. He reported, however, that
his wife could tell by his changed facial expression that he was
about to have one.
3.2.2.4. Challenges to the implementation of CBT. One of the challenges
that patients reported as part of CBT was being able to engage with
the tasks, often because of emotional or behavioral avoidance. Two
male participants recalled how they did not want to engage with the
techniques and the homework materials given to them by their CBT
therapists because they could not see the value of either. Another fe-
male CBT participant felt that she was unable to write down her emo-
tions as part of her homework as this was too distressing to do
outside of therapy sessions.
For one woman in the CBT + SMC group who had been frequently
housebound and had high levels of social anxiety, behavioral experi-
ments such as walking into town proved very difficult. She recalled
her fear of attempting behavioral experiments such as walking around
in public with the therapist at her side:
“And we walked from the hospital to the town and that was just, yeah,
mental. I actually feel like I could have strangled her (the therapist)…
You're not just frightened of the seizure but what other people are going
to do. Are they going to hurt you, are they going to kick you?… And are
cars going to run you over and are people going to look at you?”
(Female, CBT + SMC, interview 13)
3.2.3. Reflections on an “unpredictable recovery”
As a number of participants in both the CBT + SMC and SMC-
alone arms reported that their interventions helped them to im-
prove seizure management and (in one of the SMC participants
and six of the 22 CBT + SMC cases interviewed here) to become sei-
zure-free at the time of interview, participants' insights into how
and why they believed that they had changed over the course of
treatment gave rise to a further theme. The process of recovery, as
perceived by a number of participants, was neither linear nor
straightforward. They felt that feeling better was not just about sei-
zure reduction but an acceptance of the seizures – or at least recog-
nizing that they did not have to be scared of them – and an
acknowledgment, and acceptance for some, of their own personality
traits or temperament.
“I think another thing was it was acceptance, acceptance of my medical
condition and acceptance of seizures, because I think up until that point
I found it very difficult to accept.”
(Male, CBT + SMC, interview 12)
3.2.3.1. Personal insights into DS and attributions for “getting my life back”.
There was a wide variation in participants' accounts of the process of
improvement. Eleven participants were able to reflect openly on a
range of factors, both external and internal, that they believed had
left them prone to developing DS in the first place. They often
recalled very difficult events such as the death of a parent at a
young age, relationship disturbances, mental health problems, or co-
morbidities such as fibromyalgia, or the potentially life-threatening
illness of a child. However, there was also insight into their own
characteristics or types of personality that they also thought had
predisposed them to stress. Three said they now understood how
they had previously been more emotionally cutoff or disconnected
from their own emotions while realizing they had put too much em-
phasis on others' emotional cues and responses.
In turn, this led almost half of the interviewed CBT+SMC group and
a quarter of the interviewed SMC-alone group to describe a type of emo-
tional shift, a process that they viewed as mainly positive and, by their
own understanding, interlinkedwith improvement. One participant de-
scribed CBT being the conduit to being open to feeling more extreme
emotions rather than living life in an emotional “gray middle”, which
he understood had been a useful coping strategy:
“I'm getting closer to that full range of feeling, which is good but it's bad
because… I guess it means that whatever I was doing in the past was
working in that I was obviously trying to avoid the extremes, so what
I was doing wasworking, my coping strategies, my copingmechanisms,
my routines were serving a purpose”
(Male, SMC-alone, interview 22)
Several CBT+ SMC participants described how therapy had encour-
aged them to feel less overwhelmed in their response to stress and
being either more vocal about their needs and emotions or more con-
sciously prioritizing them over the needs of others. Just over a third of
the CBT + SMC and a quarter of the SMC-alone interviewees had
come to realize how much anxiety, worry, anger, and frustration they
had been holding on to over the years, which had been highlighted in
sessions either with the CBT therapist or the psychiatrist. One CBT +
SMC participant described how she had becomemore openly emotional
and how therapy had shown her the importance of being able to cry in
front of others. For another, having CBT was the catalyst for having the
courage to separate fromher partner, and a third CBT+SMCparticipant
felt that therapy had enabled her to speak up for herself in her current
relationship. Conversely, a fourth participant receiving CBT expressed
her bewilderment that feeling any positive or negative emotion contin-
ued to be sufficient in itself to trigger a seizure. A participant in the SMC-
alone arm felt that it was the diagnosis itself, which had been the turn-
ing point or validation, that allowed him to bemore honest with others
about his own emotional state:
“Whereas getting that diagnosis felt I could probably be a bit more, a bit
more, not much, a bit more open…about, ‘Look I'm not feeling great to-
day.’”
(Male, SMC-alone, interview 10)
However, not everyone felt any significant emotional shift. For one
female participant in the CBT + SMC arm (who was seizure-free at
the point of interview), therapymade her aware of the very high expec-
tations she continually set herself, but she was not able to change this
within the course of treatment.
Despite the diagnostic approach and how it was communicated in
the study, there were variations in participants' attributions of the
causes of their seizures. For three participants, the reduction in seizures
was attributed by them to not only receiving the correct diagnosis but
also to external factors such as antidepressants (SMC participant), a
change in heart medication, which the participant felt stopped her fall-
ing (SMCparticipant), that in turn led her to a complete cessation of sei-
zures and, in the third case (CBT + SMC participant), a sleep apnea
machine that the participant said had enabled her to sleep properly
for the first time in a long time.
3.2.3.2. Accepting partial improvement. Ten participants across the two
treatment arms reflected on their acceptance that progress and
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improvement may be partial or as unpredictable as the seizures them-
selves. Coming to terms with the random nature of DS was viewed by
a few as a vital component of the process of change. Three participants
also recognized that feeling betterwas something that had to beworked
at and that becoming seizure-free or improving seizure management
could not be taken for granted.
“I am still on the path to success for the dissociative seizures, because it's
a long road and that road has got a few bumps in it [laughs]. While I
have the bumps, particularly because I've had a few bumps soon after
I finished the CBT and so it's not that I question whether the CBT has
worked, I know it's worked, but it's a question of whether I've got my
act together enough, or whether I've been lazy and not been continuing
the work after the sessions.”
(Male, CBT + SMC, interview 12)
Acceptance of DS unpredictability was linked to improvement and
equally to being able to reconnect to the enjoyments of life prior to DS:
“It's thinking about it differently and if I do have a seizure, that's okay,
it's not the end of the world whereas before it did feel like this is it, this
is my life, it's never going to get better, I can't stand it, it's very, very de-
bilitating. It's not anyway nearly as debilitating as it was.”
(Female, CBT + SMC, interview 23)
3.2.3.3. Ongoing support. Seven of the eight participants in the CBT +
SMC group who were seizure-free at the time of interview felt there
was no need for further psychological input. However, a further eight
participants in the CBT + SMC group and one in the SMC alone group,
who had experienced a reduction in seizures, felt that they needed fur-
ther support and said they wanted to embark on further therapy. One
CBT+ SMC participant who had been seizure-free for most of the treat-
ment trial felt that starting a part-time job had triggered a small number
of seizures, which (at the point of interview, i.e., after the end of the
trial) had prompted her to consider the possibility of accessing CBT
privately.
Avoidance of traumatic memories characterized some of our partic-
ipants prior to therapy. Nineteen of the interviewees in this study spoke
explicitly or implicitly about some sort of perceived trauma. For 14 of
the CBT + SMC participants and three of the SMC participants, having
a therapist or psychiatrist that they could talk to was described as a
turning point in terms of feeling able to trust someone enough to dis-
close previously undisclosed – and what were, for some – traumatic
events. Two women in the CBT + SMC arm said the powerful emotions
and increase in seizures accompanying these recollections were over-
whelming and almost derailed therapy. They felt they needed ongoing
trauma-focused therapy after CODES support had ended despite having
a very positive therapeutic alliance with the psychiatrist as well:
“It is like a sleeping dragon that has been poked and prodded and is now
roaring and affecting everything, absolutely everything, and I'm left
with nothing. Worse than nothing really because it's awoken, and it
won't get back to sleep.”
(Female, CBT + SMC, interview 23)
4. Discussion
The aim of our qualitative study was to explore the experiences of
participants with DS who had taken part in an RCT comparing SMC-
alone with DS-specific CBT in addition to SMC. The CODES study
employed a specific care pathway involving neurologists and psychia-
trists (plus CBT for those allocated to receive it) and a range of trial-spe-
cific components [12]. Gordon [24] highlighted the importance of
researching the client's view of psychotherapy. Examining these issues
qualitatively enriches the understanding of what treatment techniques
might help improve seizure management but also throws light on what
might underlie lack of treatment success or what might make the treat-
ment process less smooth.
The first theme discussed herewas the experience of taking part in a
trial. To our knowledge, this is the first qualitative study to ask people
with DS whether taking part in a treatment trial had been acceptable.
Participants said they understood the need for randomization and that
it had been fully explained. Only half of the participants had wanted
as much treatment as might be on offer (CBT+ SMC), as many recalled
feeling a mixture of apprehension or skepticism about having 12 CBT
sessions; future treatment studies should bear such apprehension in
mind when discussing trial requirements with participants prior to
enrolment. For themajority, trial participation had resulted fromhaving
no other treatment options available or offered to them. For just over
half of those interviewed here, taking part in the trial had been of
value, and treatment had led to improvement, i.e., either a reduction
in or discontinuation of seizures, while for others, it meant an improve-
ment in their acceptance of the seizures. Most participants had felt sup-
ported by the health professionals in the study. A majority of
interviewees felt that the written materials in booklet form were very
helpful as they could re-read them in their own time and provide infor-
mation to explain DS to others.
The second theme was the relative helpfulness of CBT techniques in
seizure management. In terms of reflections regarding seizure manage-
ment, having an element of control over seizures was seen as crucial to
any path towards positive change. The clear majority of CBT + SMC in-
terviewees felt that breathing and distraction techniques learnt during
the study had allowed them to gain some control over the seizures
and, with it, the disruption of previous cycles of avoidance. Indeed,
such techniques have been recommended elsewhere for managing DS
[25]. Most of the participants interviewed here reported that they had
been exposed to a range of CBT techniques that could be practiced easily
(and on an ongoing basis) to prevent or interrupt behavioral/cognitive/
emotional chain of events in DS. Thesewere perceived to have been cru-
cial to their seizure management and, for some, their path to improve-
ment. Previous research has highlighted the sense of powerlessness
and uncontrollability [26] felt amongpeoplewith DS aswell as an exter-
nal locus of control. It is encouraging, therefore, that so many partici-
pants reported continuing to use these techniques several months
after therapy had stopped.
The importance of the therapeutic relationship between the patient
and both the therapist and psychiatrist reported here supports previous
research concerning the relationship between a positive therapeutic al-
liance and treatment outcomes in psychotherapy [27]. The present
study showed that participants in both treatment arms believed that
having a positive therapeutic alliance (either with the CBT therapist or
with the psychiatrist or both) had contributed towards them becoming
more aware and connected to their emotions and evenmore expressive
of them in front of others.
Emotional avoidance on the part of our participants posed chal-
lenges to the implementation of CBT techniques, despite being identi-
fied as important for therapists to address. Several studies have
previously highlighted the role of emotional avoidance, disconnected-
ness, or alexithymia in people with DS [16,28–31]. More specifically,
Cullingham et al. [32] found higher levels of experiential avoidance (a
broad range of avoidance encompassing both behavioral and cognitive
strategies that are used to avoid distressing or difficult personal experi-
ences as a result of fear of those experiences) in people with DS when
compared with those with epilepsy or healthy controls. We have also
recently shown [33] that our overall sample of patientswithDS entering
the RCT had high levels of belief in the unacceptability of experiencing
or expressing negative emotions. Our qualitative study builds on these
previous studies and showed some evidence that CBT had allowed
some participants to engage more fully with their emotions (a change
that they viewed as positive) and to be less fearful of the consequences
of doing so. This is of particular clinical relevance and needs further
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consideration in future treatment trials, since it has been proposed that
the avoidance of emotions may be one factor that perpetuates the diffi-
culties associated with poorer quality of life in people with DS [34]. We
further speculate that difficulty in emotional expression and in recog-
nizing the associations between emotions and seizure occurrence may
be one factor common to those patients whomay have found treatment
difficult, and this poses further challenges for those providing therapy
for this patient group.
Participants, particularly in the CBT + SMC group, felt that improve-
ment was not just linked to seizure management but also to the accep-
tance of the apparently unpredictable nature of the seizures themselves,
in particular for individuals with no specific warning signs or possibly
thosewhohadno recollection of their seizures or preceding events. Of po-
tential relevance here, Cope et al. [35] believe that there is evidence for
using third wave CBT, acceptance and commitment therapy (ACT) in
the treatment of DS. While the DS-specific CBT used in the CODES trial
was more traditional (focusing on challenging and changing thoughts
and beliefs), ACT focuses on altering the person's relationship to their
thoughts, feelings, and physical experiences. However, if therapists con-
sider offering patients ACT or other models of psychotherapy, the evi-
dence-base should be taken into account. It is important to note that for
interventions other than the DS-specific CBT evaluated in the CODES
trial, evidence is not available from adequately powered multicenter
RCTs. In addition, the specific effects of some third wave interventions
such as mindfulness on the experience of dissociative phenomena are
unknown.
Our findings suggest that the course of improvement was variable
for participants in both groups. Being protocol-driven, the number and
content of the CBT sessions was predetermined, but it was recognized
that, at the end of the study, additional interventions might be war-
ranted, although not for all participants. For two of the participants in
the CBT + SMC group, the emotional processing of trauma in therapy
meant that they had become more unwell or had got worse before
they got better. Although a temporary worsening of symptoms is com-
monwhen treating patients, ourfindings attest to the importance of on-
going work by the individual to manage the condition after therapy
ends, i.e., using CBT techniques long after therapy in the trial had been
completed. For other participants, fewer sessions may have been suffi-
cient, and it is possible that outcome may not be directly related to
the number of sessions attended, suggesting that to some extent at
least, individual tailoring of the length of treatment may be helpful.
4.1. Strengths and limitations of this study
Although previous qualitative analyses have described reactions to
therapy [13], our study focuses in depth on the experience of receiving
DS-specific CBT and accompanying SMC. This studywill ultimately com-
plement our quantitative analysis from the CODES study.
One of the limitations of this study is the potential for respondent
bias. In some cases, research workers carrying out the interviews were
known to participants as they had collected outcome data from them
during the study. This could have led participants to feel pressured to
be less critical of the study. Conversely, participants may have felt suffi-
ciently comfortable with the research worker to disclose difficult infor-
mation. A further limitation is that one of the CBT + SMC participants
did not receive any follow-up sessions in SMC and so was unable to
comment on any experience of SMC components during the interview.
In addition, all our participants hadmet the trial's eligibility criteria [12]
and had been willing to accept referral to a psychiatrist and take part in
CBT if allocated to that treatment arm, and take part in this qualitative
study, potentially making them less representative of people with DS
overall. The ethnic composition of the sample was heavily biased to-
wards white British, although this reflects the composition of the
wider population fromwhich theRCT samplewas drawn [22]. Nonethe-
less, other cultural backgrounds might give rise to the need to address
different beliefs about DS and the contexts in which they might occur
[36], and might affect whether patients attend treatment sessions. In
addition, the specific care pathway and protocol followed in the
CODES study may have led participants to be better informed about
their condition by the time they met with their psychiatrists and com-
menced CBT than might typically be the case. Finally, while we believe
that we reached a saturation and consistency of themes in relation to
our CBT + SMC participants, we cannot be certain that interviewing a
larger number of SMC participants would not have yielded more
themes, despite our best efforts to capture diversity through purposive
sampling.
5. Conclusions
Participants in this study were a diverse, heterogeneous group of in-
dividuals. The findings show the feasibility and acceptability among
people with DS of taking part in an RCT offering DS-specific CBT from
therapists and specialist medical care from neurologists and psychia-
trists. Participants in the CBT + SMC arm of the trial found breathing
techniques and distraction to be very important in helping with seizure
management and control. Positive change was not always a matter of
becoming seizure-free but included finding ways of managing DS
occurrence.
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